Tuesday
,
September
07
,
2010
TEXT_SIZE
Home
Our Products
HIV / AIDS
Malaria
RSV
Influenza
Herpes Simplex
Virosome
Our Company
Management Strategy
Corporate Profile
Management Profiles
Jacques-François Martin, CEO
Ronald Kempers, CFO
Dr. Sylvain Fleury, CSO
Dr. Toon Stegmann, CSO NL
Scientific Advisory Board
Dr. Stanley A. Plotkin
Dr. Marc Girard
Dr. Morgane Bomsel
Dr. Ronald H. Gray
Dr. M. William Makgoba
Dr. Soulemane Mboup
Dr. Juliana McElrath
Dr. Odile Puijalon
Dr. Caetano Reis e Sousa
Dr. Ruth Ruprecht
Key Partners
Investor Relations
Investor Relations Contacts
Press Releases
Industry Press Articles
Filings
Contact us
Press Releases
Title Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
11
December 03, 2008 -- Mymetics Corporation announces initial research coverage by Khandaker Partners
12
September 23, 2008 -- Mymetics Corporation now Blue Sky registered in 44 States
13
September 16, 2008 -- Successful Results for Mymetics Corporation’s Mucosal HIV/AIDS vaccine ViralChallenge significantly exceeds expectations
14
July 31, 2008 -- Letter to the Shareholders
15
May 19, 2008 -- Mymetics Corporation Acquires Preventive Malaria Vaccine From Pevion Biotech AG (Switzerland)
16
February 14, 2008 -- MA European Healthcare Consortium, including MYMETICS Corporation, awarded €7.50 Million grant
17
June 29, 2007 -- Mymetics Expands Board of Directors with the Addition of Dr. Thomas Staehelin
18
June 07, 2007 -- Mymetics'HIV Vaccine Demonstrates First-Ever Production of Mucosal Neutralizing IgA Antibodies in Non-human Primate Model
19
March 29, 2007 -- Mymetics'HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
20
March 09, 2006 -- NIH Plan to test HIV-AIDS Vaccine
Page 2 of 2
Start
Prev
1
2
Next
End
Sitemap
Privacy policy
Legal notice
Top
© COPYRIGHT Mymetics 2009